Chapter 22. Analysis of Key Characteristics of Human Carcinogens

Total Page:16

File Type:pdf, Size:1020Kb

Chapter 22. Analysis of Key Characteristics of Human Carcinogens part 3. statistical analyses of concordance and key characteristics chapter 22. Analysis of key characteristics of human carcinogens Daniel Krewski, Mustafa Al-Zoughool, Michael Bird, Nicholas Birkett, Mélissa Billard, Brittany Milton, Jerry M. Rice, Vincent J. Cogliano, Mark A. Hill, Julian Little, and Jan M. Zielinski (deceased) in collaboration with other participants (see the Contributors list) in the Workshop on Tumour Site Concordance and Mechanisms of Carcinogenesis, which was convened by IARC in April and November 2012 in Lyon Introduction evaluate and integrate the evidence limited evidence of carcinogenicity, provided by human epidemiological inadequate evidence of carcinogen- PART 3 Since its establishment in the ear- studies, animal cancer bioassays, icity, or evidence suggesting lack of CHAPTER 22 ly 1970s, the IARC Monographs and information on possible biolog- carcinogenicity. The information on Programme has evaluated more ical mechanisms of action, to clas- biological mechanisms of action may than 1000 agents with evidence of sify agents into one of the following be evaluated as strong, moderate, or human exposure and for which some categories: carcinogenic to humans weak, and is taken into consideration suspicion exists of an increased (Group 1), probably carcinogenic to in the overall evaluation. cancer risk to humans. The IARC humans (Group 2A), possibly carci- The role of mechanistic informa- Monographs Programme has devel- nogenic to humans (Group 2B), not tion in evaluating carcinogenicity oped detailed criteria against which classifiable as to its carcinogenicity to has increased substantially during to evaluate the available scientific humans (Group 3), and probably not the history of the IARC Monographs evidence on the carcinogenic poten- carcinogenic to humans (Group 4). Programme. In 1991, IARC convened tial of such agents. These criteria, These evaluations involve classifying a Working Group on the Use of Data which are described in the Preamble the data from both the human and on Mechanisms of Carcinogenesis to the IARC Monographs (Cogliano the animal studies as providing suf- in Risk Identification, to explore how et al., 2004; IARC, 2006), are used to ficient evidence of carcinogenicity, mechanistic data could be used to Part 3 • Chapter 22. Analysis of key characteristics of human carcinogens 257 identify agents with the potential to processes at the cellular and mo- electrophile can react with cellu- cause cancer in humans. The con- lecular level and thought to be rele- lar macromolecules such as DNA, sensus report of the Working Group vant to carcinogenesis. Information RNA, and proteins to form adducts. documented several mechanisms on these 24 end-points was derived Some chemical carcinogens are di- that were considered to be relevant from human in vivo, human in vitro, rect-acting electrophiles (e.g. form- to human carcinogenesis at that animal in vivo, and animal in vitro aldehyde; sulfur mustard, and ethyl- time, including genotoxicity, cell studies (see Al-Zoughool et al., 2019). ene oxide), whereas others require proliferation, receptor mechanisms During the November 2012 meeting, biotransformation by enzymes in a in mitogenesis, alterations in DNA the Workshop participants identified process termed metabolic activation repair, intercellular communication, 10 broader key characteristics of car- (e.g. polycyclic aromatic hydrocar- and immune defects and immuno- cinogens (see Chapter 10, by Smith, bons and benzene) (Miller, 1970). suppression (Vainio et al., 1992). and Smith et al., 2016). Information Characteristic 2: Is genotoxic Toxicokinetic and other variables on these characteristics was extract- were also identified as factors affect- ed from the IARC Monographs and Genotoxicity is the ability to induce ing multistage carcinogenesis. Since used to develop a database of key DNA damage or other chromosomal 1991, IARC (2006) and other orga- characteristics for Group 1 agents alterations, as measured by three nizations – for example, the United (see Al-Zoughool et al., 2019). This associated toxicological end-points: States National Toxicology Program chapter focuses on the key charac- (i) DNA damage: an alteration in (National Toxicology Program, 2014) teristics of the Group 1 agents iden- the chemical structure or integrity of DNA, including a break in a DNA and the United States Environmental tified in the IARC Monographs up to strand, and/or chemical modifica- Protection Agency (EPA) (EPA, and including Volume 106, and pre- tions such as covalent binding to 2005) – have stressed the increas- sents the results of an exploratory the nucleotide bases (Hoeijmakers, ing importance of mechanistic infor- analysis of this database. 2009); (ii) gene mutations: changes mation in cancer risk assessment. in the normal nucleotide sequence of Related risk assessment practic- Methods cellular DNA that may have a central es concern mode of action (Meek Key characteristics role in human carcinogenesis (Ding et al., 2014) and pathways of toxic- et al., 2008); (iii) clastogenic effects ity (Krewski et al., 2014; Bourdon- As mentioned above, Chapter 10, reflect damage to chromosomes, in- Lacombe et al., 2015; Cote et al., by Smith, and Smith et al. (2016) cluding DNA breakage, or the rear- 2016), as well as dosimetric consid- describe 10 key characteristics of rangement, gain, or loss of chromo- erations (Gurusankar et al., 2017). human carcinogens, as listed in some fragments (Snyder, 2010). This chapter examines the avail- Table 22.2. The toxicological end- Characteristic 3: Alters DNA able data on mechanisms of action points initially considered by the repair or causes genomic of the Group 1 agents identified up Workshop participants and used instability to and including Volume 106 of the as indicators of these characteris- IARC Monographs (Table 22.1). The tics are also noted in Table 22.2. Alterations in DNA repair result in de- present analysis is based on a re- A brief summary of each of these fects in processes that monitor and view of human cancer mechanisms, characteristics and the associated correct DNA replication fidelity. Such conducted by the participants in the toxicological end-points is provided defects can confer strong mutator two-part Workshop on Tumour Site below. phenotypes that result in genomic Concordance and Mechanisms of instability. Characteristic 1: Is electrophilic Carcinogenesis, which was con- or can be metabolically Characteristic 4: Induces vened by IARC in April and Novem- activated to electrophiles epigenetic alterations ber 2012 in Lyon. This approach initially involved retrieval of informa- The first characteristic refers to Induced epigenetic alterations are tion from the IARC Monographs on agents that act as electrophiles stable changes in gene expression 24 toxicological end-points identi- themselves or that can be metab- and chromatin organization that are fied as likely indicators of biological olized to form electrophiles. An independent of mutation and that 258 Table 22.1. Number of Group 1 agents in Volumes 100–118 of the IARC Monographs, by type of agenta Type of agent Volume Total 100 105 106 107 109 110 111 113 114 117 118 Pharmaceuticals 23 – – – – – – – – – – 23 Biological agents 11 – – – – – – – – – – 11 Arsenic, metals, 10 – – – – – 2b – – – – 12 fibres, and dusts Radiation 18 – – – – – – – – – 1c 19 Personal habits and 12 – – – – – – – 1d – – 13 indoor combustions Chemical agents and 33 1e 1f 2g 2h 1i – 1j – 1k 1l 43 related occupations Total 107 1 1 2 2 1 2 1 1 1 2 121 a At the time that the present analysis was conducted, mechanistic information was available only for the 109 Group 1 agents evaluated in the IARC Monographs up to and including Volume 106. b Fluoro-edenite fibrous amphibole; occupational exposures associated with the Acheson process in the manufacture of silicon carbide fibres. c Ultraviolet radiation from welding. d Processed meat. e Diesel engine exhaust. f Trichloroethylene. g Polychlorinated biphenyls (PCBs); dioxin-like PCBs. h Outdoor air pollution; particulate matter in outdoor air pollution. i 1,2-Dichloropropane. j Lindane. k Pentachlorophenol (PCP). l Welding fumes. can be inherited through cell divi- reactive oxygen and detoxification of leading to the recruitment and acti- sion. Epigenetic phenomena include the radical species within cells and vation of inflammatory cells. Strong genomic imprinting, X-chromosome tissues. Reactive oxygen species links exist between inflammation PART 3 inactivation, global reconfiguration induce a cascade of events that can and the induction of oxidative stress CHAPTER 22 of the DNA methylome, changes in include DNA mutation and oxidative and genomic instability; this makes chromatin compaction states and DNA damage. Both are key events in it difficult to separate out the rel- histone modification patterns, and carcinogenesis (Klaunig et al., 2011). ative importance of each of these altered expression of microRNAs mechanisms. These linkages might Characteristic 6: Induces (miRNAs). These phenomena occur be the basis of the relationship be- chronic inflammation during organ development and con- tween chronic inflammation and can- tribute to the lineage-specific epi- Chronic inflammation can arise from cer (Multhoff and Radons, 2012). genome that is maintained over the persistent infection (e.g. with human Characteristic 7: Is lifetime of an organism. papillomavirus or with Helicobacter immunosuppressive pylori) as well as from exogenous ir- Characteristic 5: Induces ritants (e.g.
Recommended publications
  • Phototoxicity of 7-Oxycoumarins with Keratinocytes in Culture T ⁎ Christophe Guillona, , Yi-Hua Janb, Diane E
    Bioorganic Chemistry 89 (2019) 103014 Contents lists available at ScienceDirect Bioorganic Chemistry journal homepage: www.elsevier.com/locate/bioorg Phototoxicity of 7-oxycoumarins with keratinocytes in culture T ⁎ Christophe Guillona, , Yi-Hua Janb, Diane E. Heckc, Thomas M. Marianob, Robert D. Rappa, Michele Jettera, Keith Kardosa, Marilyn Whittemored, Eric Akyeaa, Ivan Jabine, Jeffrey D. Laskinb, Ned D. Heindela a Department of Chemistry, Lehigh University, Bethlehem, PA 18015, USA b Department of Environmental and Occupational Health, Rutgers University School of Public Health, Piscataway, NJ 08854, USA c Department of Environmental Science, New York Medical College, Valhalla, NY 10595, USA d Buckman Laboratories, 1256 N. McLean Blvd, Memphis, TN 38108, USA e Laboratoire de Chimie Organique, Université Libre de Bruxelles, B-1050 Brussels, Belgium ARTICLE INFO ABSTRACT Keywords: Seventy-one 7-oxycoumarins, 66 synthesized and 5 commercially sourced, were tested for their ability to inhibit 7-hydroxycoumarins growth in murine PAM212 keratinocytes. Forty-nine compounds from the library demonstrated light-induced 7-oxycoumarins lethality. None was toxic in the absence of UVA light. Structure-activity correlations indicate that the ability of Furocoumarins the compounds to inhibit cell growth was dependent not only on their physiochemical characteristics, but also Psoralens on their ability to absorb UVA light. Relative lipophilicity was an important factor as was electron density in the Methoxsalen pyrone ring. Coumarins with electron withdrawing moieties – cyano and fluoro at C – were considerably less 8-MOP 3 Phototoxicity active while those with bromines or iodine at that location displayed enhanced activity. Coumarins that were PAM212 keratinocytes found to inhibit keratinocyte growth were also tested for photo-induced DNA plasmid nicking.
    [Show full text]
  • Phototoxicity of 7-Oxycoumarins with Keratinocytes in Culture T ⁎ Christophe Guillona, , Yi-Hua Janb, Diane E
    Bioorganic Chemistry 89 (2019) 103014 Contents lists available at ScienceDirect Bioorganic Chemistry journal homepage: www.elsevier.com/locate/bioorg Phototoxicity of 7-oxycoumarins with keratinocytes in culture T ⁎ Christophe Guillona, , Yi-Hua Janb, Diane E. Heckc, Thomas M. Marianob, Robert D. Rappa, Michele Jettera, Keith Kardosa, Marilyn Whittemored, Eric Akyeaa, Ivan Jabine, Jeffrey D. Laskinb, Ned D. Heindela a Department of Chemistry, Lehigh University, Bethlehem, PA 18015, USA b Department of Environmental and Occupational Health, Rutgers University School of Public Health, Piscataway, NJ 08854, USA c Department of Environmental Science, New York Medical College, Valhalla, NY 10595, USA d Buckman Laboratories, 1256 N. McLean Blvd, Memphis, TN 38108, USA e Laboratoire de Chimie Organique, Université Libre de Bruxelles, B-1050 Brussels, Belgium ARTICLE INFO ABSTRACT Keywords: Seventy-one 7-oxycoumarins, 66 synthesized and 5 commercially sourced, were tested for their ability to inhibit 7-hydroxycoumarins growth in murine PAM212 keratinocytes. Forty-nine compounds from the library demonstrated light-induced 7-oxycoumarins lethality. None was toxic in the absence of UVA light. Structure-activity correlations indicate that the ability of Furocoumarins the compounds to inhibit cell growth was dependent not only on their physiochemical characteristics, but also Psoralens on their ability to absorb UVA light. Relative lipophilicity was an important factor as was electron density in the Methoxsalen pyrone ring. Coumarins with electron withdrawing moieties – cyano and fluoro at C – were considerably less 8-MOP 3 Phototoxicity active while those with bromines or iodine at that location displayed enhanced activity. Coumarins that were PAM212 keratinocytes found to inhibit keratinocyte growth were also tested for photo-induced DNA plasmid nicking.
    [Show full text]
  • Part IV: Basic Considerations of the Psoralens
    CORE Metadata, citation and similar papers at core.ac.uk Provided by Elsevier - Publisher Connector THE CHEMISTRY OF THE PSORALENS* W. L. FOWLKS, Ph.D. The psoralens belong to a group of compoundsfled since biological activity of the psoralens and which have been considered as derivatives ofangelicins has been demonstrated. They appear coumarin, the furocoumarins. There are twelveto have specific biochemical properties which different ways a furan ring can be condensed withmay contribute to the survival of certain plant the coumarin molecule and each of the resultingspecies. Specifically these compounds belong to compounds could be the parent for a family ofthat group of substances which can inhibit certain derivatives. Examples of most of these possibleplant growth without otherwise harming the furocoumarins have been synthesized; but natureplant (2, 3, 5). is more conservative so that all of the naturally It is interesting that it was this property which occurring furocoumarins so far described turnled to the isolation of the only new naturally out to be derivativesof psoralen I or angelicinoccuring furocoumarin discovered in the United II (1). States. Bennett and Bonner (2) isolated tharn- nosmin from leaves of the Desert Rue (Tham- n.osma montana) because a crude extract of this 0 0 plant was the best growth inhibitor found among /O\/8/O\/ the extracts of a number of desert plants sur- i' Ii veyed for this property, although all the extracts showed seedling growth inhibition. One could I II speculate as to the role such growth inhibition plays in the economy of those desert plants These natural derivatives of psoralen and angeli-when survival may depend upon a successful cm have one or more of the following substituentsfight for the little available water.
    [Show full text]
  • Evaluation of Methoxsalen in the Treatment of Vitiligo Irving D
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector EVALUATION OF METHOXSALEN IN THE TREATMENT OF VITILIGO IRVING D. LONDON, M.D. Montgomery, Atabamo The value of the psoralen compounds in theviolet light from a General Electric R.S. Sunlamp treatment of vitiligo has been documented inbulb. The amount of exposure was gradually in- this country since 1952 (1—6). Vitiligo is a dis-creased, based on the patient's tolerance. Another ease of unknown etiology in which the pigmentgroup was treated by topical application of one rarely if ever has been known to return spon-per cent methoxsalen paint over small patches of vitiligo followed by exposure to sunlight or sun- taneously to the involved areas (see p. 281).lamp. At first, both 8-methoxypsoralen (methox- No statistical analysis will be attempted in this salen) and 8-isoamylenoxypsoralen were usedpaper for several reasons. First, several patients together in capsules for oral administration andwere lost from view after several months of treat- mixed in a cream for topical use. Since 1955,ment. Some were seen at distant clinics and these only methoxsalen has been used, after Kanofrecords were not available during the preparation (5) found that this compound was as effectiveof this paper. A few patients had to stop taking when used alone as when combined with 8-the drug because of toxic reactions. Lastly, the isoamylenoxypsoralen. When methoxsalen, eithertechnics of administration of the psoralens were not always comparable. I shall, therefore, discuss applied topically or taken orally, is followed bynot statistics but the results in general of the exposure to gradually increasing doses of sun-various technies especially as they pertain to light or artificial ultraviolet light, gradual re-individual patients.
    [Show full text]
  • Psoralen Photochemistry and Nucleic Acid Structure
    0022-202X/ 8 1/ 770 1-00J9$02.00/ 0 THE JOURNAL OF I NV r, STIGATIVE DEIlMATOLOGY, 77:39-44, IH8 1 Vol. 77, No. I Copy righ t © 198 1 by The Williams & Wilkins Co. Printed ill U.S.A. Psoralen Photochemistry and Nucleic Acid Structure JOHN E. H EARST, PH.D. Departm.ent of Chemistry, University of California, B erkeley, California, U.S.A . Many new psorale n derivatives have b een synthesized nated in the production of many new psoralens, several of which in an effort to enhance their water solubility and their have superior photoreactivity with both DNA and RNA as binding to nucleic acids. Availability of the very soluble compared to TMP and 8-MOP. The 5 new derivatives shown strongly binding compounds has improved our abilities here are 4' adducts of TMP and their structW"es ru-e shown (3 - to follow the optical changes associated with the photo­ 7). T he complete characterization of methoxymethyltrioxsalen chemistry of psoralens with DNA. Changes in both ab­ (MMT, 4) , hydroxymethyltrioxsalen (HMT, 5) and aminome­ sorbance and fluoresce nce are prese nted in this r eview. thyltrioxsalen (AMT, 7) wi th respect to their reactivity with A kinetic model for the photochemistry concludes that nucleic acids, including a theoretical treatment, is described in the detailed kinetics is dominated by the equilibrium a recent paper by Isaacs et al [6]. A related set of soluble 8- constant for intercalation of the psoralen in the DNA, methoxypsoralen derivatives have been synthesized by Isaacs, the quantum yield for photoaddition to DNA once inter­ Chun, a nd Hearst [7] a nd ru'e listed as compounds 8-11.
    [Show full text]
  • Bergapten Drives Autophagy Through the Up-Regulation of PTEN
    De Amicis et al. Molecular Cancer (2015) 14:130 DOI 10.1186/s12943-015-0403-4 RESEARCH Open Access Bergapten drives autophagy through the up-regulation of PTEN expression in breast cancer cells Francesca De Amicis1,2†, Saveria Aquila1,2*†, Catia Morelli1, Carmela Guido2, Marta Santoro2, Ida Perrotta3, Loredana Mauro1, Francesca Giordano1, Alessandra Nigro3, Sebastiano Andò1,2* and Maria L. Panno1* Abstract Background: Bergapten (5-methoxypsoralen), a natural psoralen derivative present in many fruits and vegetables, has shown antitumoral effects in a variety of cell types. In this study, it has been addressed how Bergapten in breast cancer cells induces autophagic process. Results: In MCF7 and ZR-75 breast cancer cells Bergapten exhibited anti-survival response by inducing the autophagic process increasing Beclin1, PI3KIII, UVRAG, AMBRA expression and conversion of LC3-I to LC3-II. LC3-GFP, Acridine orange assay and transmission electron microscopy even confirmed the increased autophagosome formations in treated cells. Bergapten-induced autophagy is dependent by PTEN up-regulation, since silencing this gene, the induction of Beclin1 and the p-AKT/p-mTOR signal down-regulation were reversed. PTEN is transcriptionally regulated by Bergapten through the involvement of p38MAPK/NF-Y, as evidenced by the use of p38MAPK inhibitor SB203580, site-direct mutagenesis of NF-Y element and NF-Y siRNA. Furthermore NF-Y knockdown prevented Bergapten-induced acid vesicular organelle accumulations (AVOs), strengthening the role of this element in mediating autophagy. Conclusions: Our data indicate PTEN as a key target of Bergapten action in breast cancer cells for the induction of autophagy. These findings add further details on the mechanism of action of Bergapten, therefore suggesting that phytochemical compounds may be implemented in the novel strategies for breast cancer treatment.
    [Show full text]
  • Dimethyl Fumarate for Plaque Psoriasis
    Horizon Scanning Centre November 2013 Dimethyl fumarate for plaque psoriasis SUMMARY NIHR HSC ID: 7758 Dimethyl fumarate is intended to be used for the treatment of moderate to severe plaque psoriasis. If licensed dimethyl fumarate may present an additional treatment option for this patient group, potentially delaying or avoiding the need for biological therapies. Dimethyl fumarate is one of three fumaric acid salts present in Fumaderm, a drug already licensed in Germany for plaque psoriasis. This briefing is Plaque psoriasis is the most common type of psoriasis, representing 90% of based on cases. The estimated UK prevalence of psoriasis is 1.5-1.63%, with 1.1% of information suffering with severe disease. It has a bimodal onset, with the first peak available at the time occurring in persons aged 16 to 22 years, and the second in persons aged of research and a 57 to 60 years. The prevalence of psoriasis in those younger than 10 years is limited literature estimated to be 0.55% and 1.4% in those aged between 10 and 19 years. search. It is not The estimated prevalence of people currently eligible for biological therapy in intended to be a England is 1.1% of those with psoriasis. Chronic plaque psoriasis is typified definitive statement by itchy, well demarcated circular-to-oval bright red/pink elevated lesions on the safety, (plaques) with overlying white or silvery scale, distributed symmetrically over efficacy or extensor body surfaces and the scalp. Current treatment options include effectiveness of the topical ointments and emollients, phototherapy, systemic therapies (e.g.
    [Show full text]
  • WO 2012/074588 A2 7 June 2012 (07.06.2012) W P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2012/074588 A2 7 June 2012 (07.06.2012) W P O P C T (51) International Patent Classification: Not classified (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, (21) International Application Number: AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, PCT/US201 1/049691 CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, (22) International Filing Date: DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, 30 August 201 1 (30.08.201 1) HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, (25) Filing Language: English MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, (26) Publication Language: English OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, (30) Priority Data: TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. 61/378,057 30 August 2010 (30.08.2010) US 61/478,700 25 April 201 1 (25.04.201 1) US (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, (71) Applicant (for all designated States except US) : PRESID¬ GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ENT AND FELLOWS OF HARVARD COLLEGE ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, MD, RU, TJ, [US/US]; 17 Quincy Street, Cambridge, MA 02138 (US).
    [Show full text]
  • A Possible Mechanism of Psoralen Phototoxicity Not Involving Direct Interaction with DNA (Receptors/Psoriasis/Vitiligo/Photocheniistry) JEFFREY D
    Proc. Natl. Acad. Sci. USA Vol. 82, pp. 6158-6162, September 1985 Cell Biology A possible mechanism of psoralen phototoxicity not involving direct interaction with DNA (receptors/psoriasis/vitiligo/photocheniistry) JEFFREY D. LASKIN*, EDMUND LEE, EDWARD J. YURKOW, DEBRA L. LASKIN, AND MICHAEL A. GALLO Department of Environmental and Community Medicine, University of Medicine and Dentistry of New Jersey-Rutgers Medical School and Department of Pharmacology and Toxicology, Rutgers University, Piscataway, NJ 08854 Communicated by Gerald N. Wogan, May 23, 1985 ABSTRACT Psoralens in combination with ultraviolet OCH3 light (UVA; 320-400 nm) are used in the photochemical 0 0 0 treatment of a variety of skin diseases including vitiligo, a skin depigmentational disorder, and psoriasis, a disease of acceler- ated epidermal cell proliferation. Although it is generally assumed that the major site of action of the psoralens is DNA, MeOPso we have obtained evidence that another site may be the primary target for these compounds. We have identified specific, saturable, high-affinity binding sites for 8-methoxypsoralen on HeLa cells and have detected specific binding of 8- methoxypsoralen to four other human cell lines and five mouse cell lines. In HeLa cells, specific binding is reversible and independent of the ability of the compound to intercalate into DNA. In addition, binding sites become covalently modified by Me3Pso the psoralen after UVA exposure. Specific binding of 8- [methoxy-l3Hlmethoxypsoralen constitutes 79% of the label FIG. 1. Structure of MeOPso and Me3Pso. bound to the cells. Scatchard analysis indicated two classes of psoralen binding sites: high-affinity sites with a Kd of 19 x 10-9 treatment of psoriasis.
    [Show full text]
  • Analysis of Bakuchiol, Psoralen and Angelicin in Crude Drugs and Commercial Concentrated Products of Fructus Psoraleae
    433 Journal of Food and Drug Analysis, Vol. 15, No. 4, 2007, Pages 433-437 藥物食品分析 第十五卷 第四期 Analysis of Bakuchiol, Psoralen and Angelicin in Crude Drugs and Commercial Concentrated Products of Fructus Psoraleae CHWAN-FWU LIN1,4, YU-LING HUANG2, MEI-YIN CHIEN3, SHUENN-JYI SHEU1* AND CHIEN-CHIH CHEN2* 1. Department of Chemistry, National Taiwan Normal University, Taipei, Taiwan (R.O.C.) 2. National Research Institute of Chinese Medicine, 155-1, Sec. 2, Li Nung St., Peitou, Taipei, Taiwan (R.O.C.) 3. Ko Da Pharmaceutical Co. Ltd., 20-1, Industrial 3 Rd., Ping-Cheng City, Tao-Yuan, Taiwan (R.O.C.) 4. Department of Cosmetic Science, Chang Gung Institute of Technology, Tao-Yuan, Taiwan (R.O.C.) ABSTRACT The goal of this study was to develop a HPLC method for simultaneously determining bakuchiol, psoralen and angelicin in Fructus Psoraleae (Buguzhi, the fruits of Psoralea corylifolia) and its commercial concentrated products. Extracted samples were analyzed by using a reverse-phase column (Cosmosil 5C18-AR-II) and eluting with a gradient mobile phase consist- ing of 20% acetonitrile to acetonitrile at a flow rate of 1.0 mL/min with detection at a wavelength of 254 nm. The relative standard deviations of the marker substances on the basis of peak-area ratios in intraday and interday analyses were 0.3~1.5% and 0.2~1.0%, respectively. Bakuchiol, psoralen and angelicin contents were 36.2~71.0, 2.5~13.0 and 2.2~9.2 mg/g for ten raw material samples of Fructus Psoraleae, and 0.6~21.1, 0.6~5.2 and 0.6~5.3 mg/g for eight commercial concentrated products of Fructus Psoraleae, respectively.
    [Show full text]
  • Trioxsalen (4,5’,8-Trimethylpsoralen)
    InterBioTech FT-423807 Trioxsalen (4,5’,8-Trimethylpsoralen) Product Description Product Name: Trioxsalen (4,5’,8-Trimethylpsoralen) Synonyms: Trioxsalen; NSC 71047; 4,5’,8-Trimethylpsoralen; Trisoralen; 2,5,9-trimethyl-7H-furo[3,2-g][1]benzopyran-7-on; Cat Number : 423807, 100mg 423808 , 500mg AX8HJ0, 1ml at 10mM in DMSO. CAS: 3902-71-4 Molecular Weight: 228.24 Purity (LCMS): >99% Solubility: in DMSO : 50 mg/mL (184.99 mM; Need ultrasonic) in H2O : < 0.1 mg/mL (insoluble) Targets: GAG; Collagen typeII Channel Pathway: - Storage: Powder : Store at -20°C for 3 years, at 4°C for 2 years (M) In solvent : Store at -80°C for 6 months, at -20°C for 1 month Description: Trioxsalen is a furanocoumarin and a psoralen derivative. After photoactivation it creates interstrand cross-links in DNA, which can cause programmed cell death. It is used in conjunction with UV-A for phototherapy treatment of vitiligo and hand eczema. Technical and Scientific Information Biological activity: Like Psoralen (#AX6fA0), Trioxsalen intercalates into DNA and forms DNA single-strand adducts and interstrand crosslinks when activated with ultraviolet light.[1][2]. Cross-links in DNA can cause programmed cell death. It is used to study DNA structure as well as the cellular response to DNA damage. It has been used in conjunction with UV-A for phototherapy treatment of vitiligo and hand eczema. Trioxsalen and other psoralens photosensitize skin cells to ultraviolet light[3]. Protocol : Solvent and solubility Invitro A stock solution may be made by dissolving the trioxsalen in the solvent of choice. Trioxsalen is soluble in organic solvent such as dichloromethane, which should be purged with an inert gas.
    [Show full text]
  • Studies on the Biosynthesis of Psoralen and Bergapten in the Leaves of Ficus Carica
    700 G. CAPORALE. F. DALL'ACQÜA. S. MARCIANI, AND A. CAPOZZI Studies on the Biosynthesis of Psoralen and Bergapten in the Leaves of Ficus carica G. C a p o r a l e , F. D a l l ’A c q u a , S. M a r c i a n i , a n d A . C a p o z z i Istituto di Chimica Farmaceutica, Centro di Chimica del Farmaco e dei prodotti biologicamente attivi, University of Padua (Italy) (Z. Naturforsch. 25 b, 700— 703 [1970] ; eingegangen am 11. März 1970) With the aim of studying the biosynthesis of psoralen and bergapten, two furocoumarins present in the leaves of “Ficus carica” (Moraceae), the Authors, continuing preceding researchs on this topic, have fed the leaves with the following labelled precursors: 4/,5/-dihydropsoralen, 4',5'-dihydro- bergapten, 7-hydroxycoumarin, 5,7-dihydroxycoumarin and 5-methoxy-7-hydroxycoumarin. The results obtained indicate that all these substances are certain biogenetic precursors for psoralen and bergapten. On the basis of the results obtained the biosynthetic pathway of furocoumarins seems to involve first of all the formation of a coumarinic derivative 7-hydroxylated, then an isoprenylation reaction which leads to the formation of the hydrogenated furan ring, finally dehydrogenation of the 4',5/-dihydrofurocoumarins to psoralen and bergapten. Psoralen (1) and bergapten (2) show, like other coumarins, while the incorporation of the other sub­ natural or synthetic furocoumarins, various inter­ stances occurred in a smaller amount. esting photobiological properties. The skin-photo- Although from the experiments with mevalonic sensitizing activity of furocoumarins has been wide­ acid — 2-14C it was not possible to establish the ly studied for several years in this Institute.
    [Show full text]